Cargando…

Can T Cells Abort SARS-CoV-2 and Other Viral Infections?

Despite the highly infectious nature of the SARS-CoV-2 virus, it is clear that some individuals with potential exposure, or even experimental challenge with the virus, resist developing a detectable infection. While a proportion of seronegative individuals will have completely avoided exposure to th...

Descripción completa

Detalles Bibliográficos
Autores principales:	Swadling, Leo, Maini, Mala K.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10002440/ https://www.ncbi.nlm.nih.gov/pubmed/36901802 http://dx.doi.org/10.3390/ijms24054371

Ejemplares similares

The past, current and future epidemiological dynamic of SARS-CoV-2
por: Balloux, François, et al.
Publicado: (2022)

Airway-resident T cells from unexposed individuals cross-recognize SARS-CoV-2
por: Diniz, Mariana O., et al.
Publicado: (2022)

Pre-existing polymerase-specific T cells expand in abortive seronegative SARS-CoV-2
por: Swadling, Leo, et al.
Publicado: (2021)

Neuromuscular Complications of SARS-CoV-2 and Other Viral Infections
por: Jacob, Sarah, et al.
Publicado: (2022)

Trace Elements as Immunoregulators in SARS-CoV-2 and Other Viral Infections
por: Dharmalingam, Karthick, et al.
Publicado: (2021)

The role of the oral cavity in SARS-CoV-2- and other viral infections
por: Hoffmann, Dieter
Publicado: (2023)

Persistent symptoms after COVID-19 are not associated with differential SARS-CoV-2 antibody or T cell immunity
por: Altmann, Daniel M., et al.
Publicado: (2023)

An ACAT inhibitor suppresses SARS-CoV-2 replication and boosts antiviral T cell activity
por: Wing, Peter A. C., et al.
Publicado: (2023)

Cross-reactive memory T cells abort SARS-CoV-2 infection
por: Flemming, Alexandra
Publicado: (2021)

The impact of viral mutations on recognition by SARS-CoV-2 specific T cells
por: de Silva, Thushan I., et al.
Publicado: (2021)

Plasma proteomic signature predicts who will get persistent symptoms following SARS-CoV-2 infection
por: Captur, Gabriella, et al.
Publicado: (2022)

Can SARS-CoV-2-infected women breastfeed after viral clearance?
por: Lang, Guan-jing, et al.
Publicado: (2020)

Defective viral genomes can protect against SARS-CoV-2 variants and other respiratory viruses
por: Flemming, Alexandra
Publicado: (2021)

Discrimination of SARS-CoV-2 Infections From Other Viral Respiratory Infections by Scent Detection Dogs
por: ten Hagen, Nele Alexandra, et al.
Publicado: (2021)

Zinc Iodide in combination with Dimethyl Sulfoxide for treatment of SARS-CoV-2 and other viral infections
por: Hoang, Ba X., et al.
Publicado: (2020)

Transcriptomic similarities and differences in host response between SARS-CoV-2 and other viral infections
por: Thair, Simone A., et al.
Publicado: (2020)

Micro-RNAs in the regulation of immune response against SARS CoV-2 and other viral infections
por: Abu-Izneid, Tareq, et al.
Publicado: (2020)

Synergistic Interferon-Alpha-Based Combinations for Treatment of SARS-CoV-2 and Other Viral Infections
por: Ianevski, Aleksandr, et al.
Publicado: (2021)

Therapeutic applications of nanobodies against SARS-CoV-2 and other viral infections: Current update
por: Bhattacharya, Manojit, et al.
Publicado: (2023)

Viral load of SARS-CoV-2 in clinical samples
por: Pan, Yang, et al.
Publicado: (2020)

Modeling the viral dynamics of SARS-CoV-2 infection
por: Wang, Sunpeng, et al.
Publicado: (2020)

Viral Cardiomyopathies Associated With SARS-CoV-2 Infection
por: Almanza-Hurtado, Amilkar, et al.
Publicado: (2022)

Viral kinetics of sequential SARS-CoV-2 infections
por: Kissler, Stephen M., et al.
Publicado: (2023)

SARS-CoV-2, the other face to SARS-CoV and MERS-CoV: Future predictions
por: Abdelghany, T.M., et al.
Publicado: (2021)

SARS-CoV-2 can infect human embryos
por: Montano, Mauricio, et al.
Publicado: (2022)

Discordant neutralizing antibody and T cell responses in asymptomatic and mild SARS-CoV-2 infection
por: Reynolds, Catherine J., et al.
Publicado: (2020)

521. Similarities and Differences in Transcriptomic Host Response between SARS-CoV-2 and Other Viral Infections
por: Thair, Simone A, et al.
Publicado: (2020)

Multivariate analyses of codon usage of SARS-CoV-2 and other betacoronaviruses
por: Gu, Haogao, et al.
Publicado: (2020)

Co-infection of SARS-CoV-2 with other viral respiratory pathogens in Yogyakarta, Indonesia: A cross-sectional study
por: Arguni, Eggi, et al.
Publicado: (2022)

Evolution of viral quasispecies during SARS-CoV-2 infection
por: Jary, Aude, et al.
Publicado: (2020)

SARS-CoV-2: The viral shedding vs infectivity dilemma
por: Widders, Arabella, et al.
Publicado: (2020)

Viral transmission in asymptomatic cases of SARS-CoV-2 infection
por: Grall, Isabelle, et al.
Publicado: (2021)

Palmitoylation of SARS-CoV-2 S protein is essential for viral infectivity
por: Wu, Zhuanchang, et al.
Publicado: (2021)

Viral and cellular translation during SARS‐CoV‐2 infection
por: Eriani, Gilbert, et al.
Publicado: (2022)

2301. Viral Kinetics of Sequential SARS-CoV-2 Infections
por: Kissler, Stephen, et al.
Publicado: (2023)

Can Some Viral Respiratory Infections Observed Before the Pandemic Announcement Be Related to SARS-CoV-2?
por: Özgen Alpaydın, Aylin, et al.
Publicado: (2023)

Viral load of SARS-CoV-2 across patients and compared to other respiratory viruses
por: Jacot, Damien, et al.
Publicado: (2020)

Respiratory mucosal immune memory to SARS-CoV-2 after infection and vaccination
por: Mitsi, Elena, et al.
Publicado: (2023)

Zinc for the prevention and treatment of SARS-CoV-2 and other acute viral respiratory infections: a rapid review
por: Arentz, Susan, et al.
Publicado: (2020)

SARS-CoV-2 versus other minor viral infection on kidney injury in asymptomatic and mildly symptomatic patients
por: Chang, Ya-Chieh, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_q462ptb74ifj4h0ievmbhn83vh